Inovio Pharmaceuticals Inc (NASDAQ:INO) - Share price - Overview


Stock Report

Inovio Pharmaceuticals Inc INO

Last Price
$3.73

Day Change
0.01|0.27%

As of 18/04/2019
17:23:48 EDT | USD
Minimum 15 Minutes Delay.

Last Close3.72
Day Range3.61 - 3.79
Mkt Cap365.30Mil
52-Wk Range3.02 - 6.30
Yield %-
ISINUS45773H2013
Volume1,282,845
P/E-3.55
P/S11.33
P/CF-4.69

Share Price

Financials
201620172018
More ...
Income Statement
Revenue35.3742.2230.48
Operating Income-77.24-84.64-94.09
Net Income-73.74-88.21-96.97
Basic EPS-1.01-1.08-1.05
Avg. Diluted Shares Outstanding738293
Balance Sheet
Current Assets124.60138.3687.81
Non Current Assets49.1148.8843.30
Total Assets173.71187.24131.11
Current Liabilities43.8235.4135.30
Total Liabilities50.3344.7544.08
Total Equity123.28142.3986.94
Cash Flow
Operating Cash Flow-62.56-63.21-73.55
Capital Expenditure-3.94-10.29-2.09
Free Cash Flow-66.49-73.50-75.64

In millions, except "Basic EPS". Currency is USD.

Company Profile

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

281
Key Stats
More ...
Price/Earning TTM-3.54
Price/Book4.19
Price/Sales TTM9.22
Rev Growth (3 year avg)-9.09
EPS Growth (3 year avg)-
Operating Margin % TTM-308.68
Net Margin % TTM-318.12
ROE TTM-84.57
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.